360
Participants
Start Date
August 31, 2003
Primary Completion Date
May 31, 2004
Study Completion Date
May 31, 2004
Ropinirole
GSK Investigational Site, Schenectady
GSK Investigational Site, Philadelphia
GSK Investigational Site, Lafayette Hill
GSK Investigational Site, Alexandria
GSK Investigational Site, Norfolk
GSK Investigational Site, Raleigh
GSK Investigational Site, Columbia
GSK Investigational Site, Atlanta
GSK Investigational Site, Augusta
GSK Investigational Site, Macon
GSK Investigational Site, Pembroke Pines
GSK Investigational Site, Boca Raton
GSK Investigational Site, Tampa
GSK Investigational Site, Tampa
GSK Investigational Site, St. Petersburg
GSK Investigational Site, Largo
GSK Investigational Site, Alabaster
GSK Investigational Site, Birmingham
GSK Investigational Site, Tuscaloosa
GSK Investigational Site, Jasper
GSK Investigational Site, Nashville
GSK Investigational Site, Louisville
GSK Investigational Site, Dublin
GSK Investigational Site, Concinnati
GSK Investigational Site, Southfield
GSK Investigational Site, Elk Grove Village
GSK Investigational Site, Chicago
GSK Investigational Site, Little Rock
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Plano
GSK Investigational Site, Dallas
GSK Investigational Site, Austin
GSK Investigational Site, Aurora
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Albuquerque
GSK Investigational Site, Henderson
GSK Investigational Site, Redondo Beach
GSK Investigational Site, Santa Monica
GSK Investigational Site, Northridge
GSK Investigational Site, La Jolla
GSK Investigational Site, Oxnard
GSK Investigational Site, Berkeley
GSK Investigational Site, Portland
GSK Investigational Site, Walla Walla
GSK Investigational Site, Stanford
GSK Investigational Site, Danbury
GSK Investigational Site, Lebanon
GSK Investigational Site, Columbus
Lead Sponsor
GlaxoSmithKline
INDUSTRY